JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Topical Vehicle Design: Educational Intervention Addresses Gap in Dermatology Resident Training

Published online March 13, 2026

Over-the-counter (OTC) products are often used as firstline or adjunctive treatments for many dermatologic conditions. 1,2 Topical for...

read more
The Safety of GLP1 Receptor Agonist Usage in Mohs Micrographic Surgery Patients

Published online March 13, 2026

To the Editor, Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are widely prescribed for type 2 diabetes and, more recently, for obesity man...

read more
Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer's Disease and Dementia

Published online February 26, 2026

Herpes simplex virus (HSV), responsible for oral and genital herpes, impacts over 3 billion people worldwide. 1 HSV-1 typically causes...

read more
Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata

Published online February 26, 2026

Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss on the scalp and body, with periods of relapse and...

read more
Transitioning from Anti-aging to Skin Activation: Limiting Cellular Fatigue and Senescence for Skin Longevity

Published online February 26, 2026

The concept of 'anti-aging' has been openly used for many years to describe a wide range of changes, from smoothing fine lines and wrin...

read more
Management of Nail Toxicities From Fibroblast Growth Factor Receptor Inhibitors

Published online February 26, 2026

Fibroblast growth factor receptor inhibitors (FGFRi) are a novel class of targeted therapies used in the treatment of FGFR-mutant malig...

read more
Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence

Published online February 26, 2026

Plaque psoriasis is a chronic immune-mediated disease driven by proinflammatory cytokines, such as interleukin (IL)-17, IL-12, IL-23, a...

read more
Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema

Published online February 26, 2026

Chronic hand eczema (CHE) is a common, heterogeneous inflammatory condition affecting the hands and wrists. Etiologic and morphologic p...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

New Video Abstract: Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation

| Featured Articles, The Latest, Video Abstract | No Comments
Check out our all-new JDD Video Abstract from Susan Taylor MD, who discusses Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation.
Journal of Drugs in Dermatology JDD Editor’s Pick, featuring February 2026 articles which is our aesthetics treatment focused issue..

JDD March 2026 Highlights and Editor Picks

| Featured Articles, JDD Highlights, Latest News | No Comments
Curated by the JDD Editors Missed any of our March highlights? March is packed with intriguing articles, and you’ll want to start to dive in! Catch up with this curated…
Journal of Drugs in Dermatology JDD Article about Practical Algorithm for Acne Treatment Integrating Skincare and Energy Based Devices

Practical Algorithm for Acne Treatment Integrating Skincare and Energy Based Devices

| Acne, Featured Articles, Latest News, Skincare | No Comments
A practical, consensus driven algorithm to help clinicians combine topical care and device therapies We wanted to share this February 2026 article that has been gaining a lot of attention.…
Journal of Drugs in Dermatology JDD Article about Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia

Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer’s Disease and Dementia

| Featured Articles, Latest News, Medical Derm | No Comments
A large real world TriNetX analysis reports an association between antiviral treatment for oral or mucocutaneous HSV and lower rates of Alzheimer disease and dementia If you’ve missed this must-read…
Journal of Drugs in Dermatology JDD Article about From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review

From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review

| Featured Articles, Latest News, Medical Derm | No Comments
Have you read this JDD review on Th17 pathway defects and chronic mucocutaneous candidiasis? We pulled this one from the JDD vault - a must read article that dates back…
Journal of Drugs in Dermatology JDD Article about From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy

From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy

| Alopecia, Case Reports, Featured Articles, Hair, Latest News, Pediatrics | No Comments
A pediatric case links dupilumab therapy for atopic dermatitis with sustained hair regrowth in extensive alopecia areata Dive into this recent JDD Case Study A single-patient case report describes a…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array of nonsteroidal options, understanding the underpinnings to both use them for their intended purpose, but even more fun, OOOOOOFFFFFF LLLLLLAAAAABBBBEEEELLLL (clearly a fan of off label), is paramount to patient outcomes. Be not overwhelmed I say, as the bench to bedside badass Dr. Christopher Bunick is here for all your on and off label needs. Take a break from the typical Tuesday with a topical translational deep dive into the tantalizing options as host Dr. Adam Friedman tees off with Dr. Bunick for what is certain to be a “tough” (as the kids say) podcast.

Touching on Tailored Topical for Tons of Tough Treatment Tchallenges

| Featured Articles, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array…
Tune In

Follow Us